Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study

By afschroeder • March 26, 2026

Fleseriu M, Biller BMK, Webb SM, Strasburger CJ, Georgescu CE, Bidlingmaier M, Wang C, Baciu I, Casanueva FF, Gilis-Januszewska A, Hart G, Manners A, Choe J, Bar-Ilan A, Carlsson M, Torre D, Taylor CT, Yuen KCJ. Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study. Pituitary. 2026 Mar 25;29(2):59. doi: 10.1007/s11102-026-01661-1. PMID: 41879875.

Tags: Adult growth hormone deficiency, body composition, Endocrinology, Harbor UCLA, IGF-I, Lean body mass, Long-acting growth hormone, Publications, Somatrogon

Retraction Note: Deficiency of endothelial sirtuin1 in mice stimulates skeletal muscle insulin sensitivity by modifying the secretome

Li Q, Zhang Q, Kim YR, Gaddam RR, Jacobs JS, Bachschmid MM, Younis T, Zhu Z, Zingman L, London B, Rauckhorst AJ, Taylor EB, Norris[...]

Hypothyroidism impairs skeletal muscle regeneration after injury by altering myogenic and nonmyogenic pathways

Aguiari P, Villani V, Liu YY, Carraro G, Brent GA, Perin L, Milanesi A. Hypothyroidism impairs skeletal muscle regeneration after injury by altering myogenic and[...]

RHOT Proteins Link Mitochondrial Motility to Cardiomyocyte Sarcomere Maturation

Froese N, Shymotiuk I, Froese A, Polten F, Jablinski J, Scholz T, Korf-Klingebiel M, Werlein C, Galuppo P, Gigina A, Wihler K, Schneider J, Erschow[...]